Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The glaucoma drainage devices market has been experiencing steady advancement, driven by the increasing prevalence of glaucoma and improvements in healthcare infrastructure. As the demand for innovative and minimally invasive treatment options rises, the market is set for considerable growth in the coming years. Let’s explore the current market size, key growth drivers, segment performance, industry trends, leading companies, and regional insights shaping this sector.

The Glaucoma Drainage Devices Market Size and Growth Outlook

The market for glaucoma drainage devices has seen significant growth recently and is expected to continue expanding. It is forecasted to increase from $0.89 billion in 2025 to $0.98 billion in 2026, representing a compound annual growth rate (CAGR) of 10.0%. Moving forward, the market is projected to reach $1.42 billion by 2030, with a CAGR of 9.7%. Factors contributing to this expansion include a rising number of glaucoma cases, more ophthalmic surgical centers, greater adoption of glaucoma surgeries, an aging global population, and increased availability of specialized eye care facilities. Additionally, ongoing innovations in device technology and a growing focus on early intervention are set to fuel further growth.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20821&type=smp

Key Factors Supporting Growth in the Glaucoma Drainage Devices Market

One major driver behind the glaucoma drainage devices market is the growing prevalence of glaucoma worldwide. Glaucoma, a group of eye disorders that damage the optic nerve typically due to elevated intraocular pressure, can lead to irreversible vision loss if untreated. The increasing incidence is linked to factors such as aging populations, urban lifestyles, and changing health patterns. Drainage devices are critical in managing intraocular pressure, especially in refractory glaucoma cases where conventional treatments fail. For example, in October 2025, The NHS Confederation reported that glaucoma affects over 700,000 people in the UK, with nearly half undiagnosed due to its asymptomatic nature and prolonged hospital waiting times. Waiting periods can be as long as 72 weeks, and eye-related conditions are expected to increase by 25% between 2022 and 2032, far exceeding population growth rates. This growing patient base is pushing demand in the glaucoma drainage devices market.

Healthcare Infrastructure Expansion’s Role in Market Growth

Another important growth driver is the enhancement of healthcare infrastructure internationally. This includes the development and expansion of hospitals, clinics, diagnostic centers, and other medical facilities that improve access to quality eye care. Increased investments by governments and private sectors, coupled with rising population and demand for advanced treatments, have strengthened healthcare systems. This growth enables the adoption of new technologies and boosts patient accessibility to specialized glaucoma care. For instance, a report from the Office for National Statistics in May 2023 noted that healthcare spending in the UK rose by 5.6% between 2022 and 2023, reaching approximately $317.63 billion (£292 billion) in 2023. Such investment supports the expanding glaucoma drainage devices market by improving treatment availability and infrastructure.

Access The Complete Glaucoma Drainage Devices Market Report:

https://www.thebusinessresearchcompany.com/report/glaucoma-drainage-devices-global-market-report

Segmentation and Market Structure of Glaucoma Drainage Devices

The glaucoma drainage devices market is categorized into several segments based on product type, surgery type, and end-user.

1) By Product Type:

– Valved Glaucoma Drainage Devices

– Non-Valved Glaucoma Drainage Devices

2) By Surgery Type:

– Conventional Glaucoma Surgery

– Minimally Invasive Glaucoma Surgery

3) By End-User:

– Hospitals

– Specialty Clinics

– Ambulatory Surgical Centers

– Other End-Users

Further breakdown under valved devices includes Ahmed Glaucoma Valve, Baerveldt Glaucoma Implant, Krupin Implant, and others. Non-valved devices comprise Molteno Implant, Schocket Implant, Foster Implant, and others. This segmentation helps to understand market dynamics and identify strategic opportunities for stakeholders.

Industry Trends Driving Innovation in Glaucoma Drainage Devices

A notable trend in the glaucoma drainage devices market is the development of next-generation canal-based surgery devices that offer safer and minimally invasive treatment options. These implants focus on the Schlemm’s canal to enhance drainage of aqueous humor, effectively reducing intraocular pressure and slowing glaucoma progression. For example, in March 2023, Nova Eye Medical Limited from Australia received approval for its iTrack Advance canaloplasty device. This microcatheterization and viscodilation tool is designed to lower intraocular pressure in adult patients with primary open-angle glaucoma. It features an ergonomic handpiece and improved technology to boost surgical accuracy and efficiency and can be used alone or alongside cataract surgery.

Key Competitors Influencing the Glaucoma Drainage Devices Market

The market is shaped by several leading companies actively engaged in innovation and competition. These include AbbVie Inc., Alcon Inc., Johnson And Johnson Vision Care Inc., Santen Pharmaceutical Co. Ltd., Glaukos Corporation, Ocular Therapeutix Inc., IRIDEX Corporation, New World Medical Inc., Ivantis Inc., iSTAR Medical, Nova Eye Medical Limited, Altomed, Aurolab, G.surgiwear Limited, Eagle Vision Inc., Advanced Ophthalmic Innovations Pte Ltd., Avisi Technologies Inc., iVeena Delivery Systems, Optonol Ltd., and Rheon-medical. These players focus on technological advances, product enhancements, and expanding global reach.

North America Leads the Market with Asia-Pacific Emerging Rapidly

In 2025, North America held the largest share of the glaucoma drainage devices market, supported by robust healthcare infrastructure and high adoption rates. Other regions covered in market analysis include Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. Among these, Asia-Pacific is expected to exhibit the fastest growth in the coming years, driven by rising healthcare investments and increasing disease prevalence. This regional diversity provides a broad perspective on global market trends and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model